News | Cardiovascular Surgery | October 24, 2022

Vascular Surgeon to Lead, Train Fellows

Donald Baril, MD, a Leading Vascular Surgeon in the Smidt Heart Institute, Named Director of the Vascular Surgery Fellowship Program 


October 24, 2022 The Smidt Heart Institute at Cedars-Sinai has selected leading vascular surgeon Donald Baril, MD, as director of the Vascular Surgery Fellowship Program. Baril, who joined Cedars-Sinai in 2020, aims to advance the academic medical center’s excellence in vascular care, research and education for current and future fellows. 

"Our Vascular Surgery Fellowship Program offers postgraduate medical education for surgeons seeking a rigorous and dynamic education leading to a notable career in vascular surgery," said Ali Azizzadeh, MD, director of the Division of Vascular Surgery in the Smidt Heart Institute at Cedars-Sinai and associate dean of Faculty Affairs. "There’s no role more important than guiding and training the next generation of vascular surgeons, and no better leader to spearhead the effort than Dr. Baril." 

The Division of Vascular Surgery supports one of the largest population centers in the U.S., Los Angeles, home to more than 9 million people. The medical center’s service area includes more than 2.5 million people, making it an ideal environment for new surgeons to receive hands-on training. 

"Our program offers comprehensive, state-of-the-art treatment for the full spectrum of vascular disorders treated by both open and endovascular procedures, which creates a robust educational experience for our trainees," said Baril. "Our mission is to create a rich tradition of educating vascular surgeons on becoming leaders in this vigorous and dynamic field." 

According to Baril, the field of vascular surgery--a subspecialty centered on diseases of the arteries, veins and lymphatic circulation--has grown in popularity and prominence over the past decade. The Smidt Heart Institute Vascular Surgery Fellowship Program has also experienced tremendous growth over the past several years.    

"We have the unique and rewarding opportunity to select the most qualified, skilled and driven fellows from across the nation," said Baril.   

Baril says he and the training team strive to produce not only technically sound surgeons and excellent clinicians, but also doctors who have a service-minded heart, team-first approach, and a "cool-under-fire" state of mind. 

"Vascular surgeons have to be willing to help, and willing to work in unpredictable environments," said Baril. "We are often the voice of reason--the firefighters of the hospital, if you will--and it has to be in our nature to roll with uncertainty while bringing our absolute best to the operating room." 

For more information: www.cedars-sinai.org 


Related Content

News | Heart Failure

April 16, 2024 — Each year more than 500,000 Americans undergo percutaneous coronary intervention, or PCI, a minimally ...

Home April 16, 2024
Home
News | Heart Failure

April 12, 2024 — University of Virginia School of Medicine researchers have discovered a gene on the Y chromosome that ...

Home April 12, 2024
Home
News | Heart Failure

April 2, 2024 — People who use e-cigarettes are significantly more likely to develop heart failure compared with those ...

Home April 02, 2024
Home
News | Heart Failure

March 29, 2024 — V-Wave announced it will present late-breaking data from its RELIEVE-HF pivotal trial at the American ...

Home March 29, 2024
Home
News | Heart Failure

March 25, 2024 — A team of engineers led by the University of Massachusetts Amherst and including colleagues from the ...

Home March 25, 2024
Home
News | Heart Failure

March 15, 2024 — BioCardia, Inc. , a biotechnology company focused on advancing late-stage cell therapy interventions ...

Home March 15, 2024
Home
News | Heart Failure

March 15, 2024 — BioCardia, Inc., a biotechnology company focused on advancing late-stage cell therapy interventions for ...

Home March 15, 2024
Home
News | Heart Failure

March 13, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home March 13, 2024
Home
News | Heart Failure

March 8, 2024 — The Texas Heart Institute, Georgia Institute of Technology (Georgia Tech), North Carolina State ...

Home March 08, 2024
Home
News | Heart Failure

March 5, 2024 — FIRE1 announced that it has completed patient enrollment in the U.S. Early Feasibility Study (FUTURE-HF2 ...

Home March 05, 2024
Home
Subscribe Now